from Reuters: U.S. https://ift.tt/2TaZCCk
Catalyst defends $375,000 drug price after Bernie Sanders rebuke
Catalyst Pharmaceuticals Inc, targeted by U.S. Senator Bernie Sanders for its high drug prices, said on Thursday that prices of its treatment for a rare neurological disorder were "in line" with similar products in the industry.
from Reuters: U.S. https://ift.tt/2TaZCCk
from Reuters: U.S. https://ift.tt/2TaZCCk
0 comments:
Post a Comment